| pubmed-article:6054165 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6054165 | lifeskim:mentions | umls-concept:C0025255 | lld:lifeskim |
| pubmed-article:6054165 | lifeskim:mentions | umls-concept:C0033693 | lld:lifeskim |
| pubmed-article:6054165 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:6054165 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
| pubmed-article:6054165 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
| pubmed-article:6054165 | lifeskim:mentions | umls-concept:C0599668 | lld:lifeskim |
| pubmed-article:6054165 | pubmed:issue | 803 | lld:pubmed |
| pubmed-article:6054165 | pubmed:dateCreated | 1967-12-20 | lld:pubmed |
| pubmed-article:6054165 | pubmed:abstractText | The capacity for binding dimethyl d-tubocurarine-C(14) was studied in isolated nerve-ending membranes from cerebral cortex and myelin. After treatment of the membrane with organic solvents most of the radioactivity was recovered in the extract. Preliminary evidence indicates that dimethyl d-tubocurarine-C(14) is not bound to lipids or glycolipids. While the proteolipids of myelin have a low binding capacity, the results obtained with the nerve-ending membranes rich in acetylcholinesterase suggest that the cholinergic receptor may be a special type of proteolipid. | lld:pubmed |
| pubmed-article:6054165 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6054165 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6054165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6054165 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6054165 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:6054165 | pubmed:issn | 0036-8075 | lld:pubmed |
| pubmed-article:6054165 | pubmed:author | pubmed-author:De RobertisEE | lld:pubmed |
| pubmed-article:6054165 | pubmed:author | pubmed-author:SotoE FEF | lld:pubmed |
| pubmed-article:6054165 | pubmed:author | pubmed-author:FiszerSS | lld:pubmed |
| pubmed-article:6054165 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6054165 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:6054165 | pubmed:volume | 158 | lld:pubmed |
| pubmed-article:6054165 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6054165 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6054165 | pubmed:pagination | 928-9 | lld:pubmed |
| pubmed-article:6054165 | pubmed:dateRevised | 2007-8-17 | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:meshHeading | pubmed-meshheading:6054165-... | lld:pubmed |
| pubmed-article:6054165 | pubmed:year | 1967 | lld:pubmed |
| pubmed-article:6054165 | pubmed:articleTitle | Cholinergic binding capacity of proteolipids from isolated nerve-ending membranes. | lld:pubmed |
| pubmed-article:6054165 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6054165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6054165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6054165 | lld:pubmed |
